| Workshops and Panel Presentations |
|
Project Lazarus: Community-Based Overdose Prevention
Tuesday, April 10, 2012, 1:00 pm – 2:00 pm |
| Moderator |
Dr. Lynn R. Webster, MD, FACPM, FASAM, Co-Founder and Medical Director, Lifetree Clinical Research, LC |
| Presenter |
Chaplain Fred Wells Brason II, CEO, Project Lazarus, and Project Director, Chronic Pain Initiative, North Carolina Community Care Network |
| Panel Description |
Established in 2006 in response to extremely high prescription drug overdose deaths in Wilkes County, N.C. (the third highest in the U.S.), the non-profit Project Lazarus enables overdose prevention by providing technical assistance to create community coalitions. Backed by the Medical Board, Project Lazarus works with health departments, law enforcement, schools, clinicians, hospitals, Medicaid, the military, Native American reservations and the faith community. In three years, overdose deaths decreased 42 percent, drug-related hospital emergency visits decreased 15 percent, prescriptions for controlled substances stabilized, new substance-abuse facilities were created, hospitals changed emergency department prescribing policies to limit opioid prescriptions, one-on-one clinical pain management education was conducted, fixed disposal sites were created for unused or expired medications, and doctors began providing pain patients and drug users with free overdose reversal kits.
This session will describe how Project Lazarus was created, how it operates, and how it can be replicated in other communities. |
| Learning Objectives |
1. Describe how Project Lazarus collaborates with community agencies to achieve a coordinated overdose prevention program.
2. Identify the five key components of Project Lazarus.
3. Explain the process for implementing Project Lazarus-type initiatives in other communities. |
|
Chronic Pain and Addiction
Tuesday, April 10, 2012, 2:15 pm – 3:45 pm |
| Moderator |
Dr. Kelly J. Clark, MD, MBA, DFAPA, Medical Director, Behavioral Health, Capital District Physicians’ Health Plan (CDPHP) |
| Presenters |
Dr. Barbara Krantz, DO, MS-Nuclear Medicine, Chief Medical Officer and Director of Medical Research, The Hanley Center; and Dr. Lynn R. Webster, MD, FACPM, FASAM, Co-founder and Medical Director, Lifetree Clinical Research, LC |
| Session Description |
There is a fine line between proper diagnosis and management of chronic pain and the urgency to curb overprescribing and/or pain pill abuse. The rate of those aged 50 and older who suffer from polypharmacy continues to rise. Participants will explore the urgency in curbing pain pill abuse, examine the surprising overdose profile, and learn about the growing incidence of abuse of specific drug classes within the context of treatment of chronic pain management.
This session examines extensive academia and clinical experiences in determining optimal treatment and intervention strategies. Also, learn about collaborative education and prevention efforts among stakeholders to limit controlled substance proliferation, while avoiding under-treating legitimate health concerns. |
| Learning Objectives |
1. Distinguish the differences between proper management of chronic pain and practices that contribute to over-prescribing and drug abuse.
2. Describe the effects and consequences of prescription pain abuse as it progresses over time.
3. Advocate the importance of continuing education on addiction for pain management providers. |
|
Treatment and Recovery in America
Tuesday, April 10, 2012, 4:00 pm – 5:30 pm |
| Moderator |
Dr. Kelly J. Clark, MD, MBA, DFAPA, Medical Director, Behavioral Health, Capital District Physicians’ Health Plan (CDPHP) |
| Presenters |
Dr. Elinore McCance-Katz, MD, PhD, Professor of Psychiatry, University of California San Francisco; and Gregory C. Warren, MA, MBA, President & CEO, Baltimore Substance Abuse Systems, Inc. |
| Session Description |
Effects of opioid addiction on individuals and communities can be devastating. Public services from emergency rooms to prisons are overwhelmed by the excessive resources and costs necessary to meet those needs, and ensure that the most effective treatment programs are utilized to reduce the rate of recidivism, lower costs, and increase successful completion rates. A must-see session providing critical information for medical professionals, law enforcement agencies, and municipalities planning or running opioid treatment programs. This presentation examines shared roles in medical decision making and use of prescribed medications and evaluates various forms of treatment and their effectiveness.
Participants will learn about prescriber and clinician support systems to assist with integrating opioid medications into a treatment plan and opioid dependence medications development. In addition, the session will present data from the National Survey on Drug Use and Health to provide an understanding of opioid abuse, discuss what clinical circumstances dictate medication-assisted treatment, review FDA-approved treatments in selecting a specific pharmacotherapy, and discuss the complex assessment and treatment of chronic pain. Discussion will include the screening, brief intervention, referral, and treatment concept. This session discusses the importance of information sharing between community-based behavioral health providers and corrections, with a particular emphasis on initiating and maintaining patients on medication-assisted treatment. Results of studies measuring the effect of treatment for substance abuse on income, as well as drug courts and their effect on recidivism and completion of probation will be discussed. |
| Learning Objectives |
1. Define when and how medication-assisted treatment methodologies for successful recovery of opioid addiction should be used.
2. Explain how to improve access and quality of care through strategic planning and community-wide coordination with local and state agencies.
3. Describe behavioral health issues faced by individuals within the corrections system and devise strategies to adequately address these clinical needs after incarceration. |
|
Drug-Exposed Infants: Trends and Challenges Panel Discussion
Wednesday, April 11, 2012, 11:15 am – 12:30 pm |
| Moderator |
Karen H. Perry, Executive Director and Co-Founder, Narcotics Overdose Prevention & Education (NOPE) |
| Panelists |
Dr. Marylou Behnke, MD, Professor of Pediatrics, University of Florida School of Medicine; Dr. Kay Roussos-Ross, MEd, MPAS, Assistant Professor, Department of Obstetrics and Gynecology, University of Florida College of Medicine; and Dr. Tamara D. Warner, PhD, Research Assistant Professor, Department of Pediatrics, University of Florida |
| Panel Description |
Medical and developmental consequences resulting from prenatal substance abuse cause significant clinical and social problems. Experts who deal with these issues in neonatal intensive care units will identify specific problems related to maternal substance abuse and present evidence of the costs associated with the treatment of drug-exposed infants. Both short-term and long-term impacts will be discussed, along with recommendations for preventing the mental, physical and psychological problems seen as these infants grow to adulthood. |
| Learning Objectives |
1. Define the symptoms of neonatal withdrawal syndrome.
2. Discuss the problems and costs related to treating drug-exposed infants.
3. Identify early intervention strategies to prevent long-term mental, physical and psychological problems. |
|
Youth and Elderly Addiction Issues
Wednesday, April 11, 2012, 1:30 pm – 3:00 pm |
| Moderator |
Peggy B. Sapp, BS, President, National Family Partnership; President & CEO, Informed Families/The Florida Family Partnership |
| Presenters |
Deborah Beck, MSW, President, Drug and Alcohol Service Providers Organization of Pennsylvania; and Michelle Muffett-Lipiniski, MEd, Founder, icanhelp(SM) Program, Principal, Northshore Recovery High School |
| Session Description |
Meeting the diverse needs of adolescents struggling with substance abuse and its co-occurring disorders requires identifying those most at-risk and creating “safe” places affording a trusting rapport with adults in the community. This session discusses the icanhelp(SM) program as a model for early engagement so adolescents can receive the essential services they need to live productive and healthy lives. Learn how to help students by fostering an ethic of honesty and mutual respect, promoting accountability, and preparing them for post-secondary education, the military or employment.
On the other end of the spectrum, older adults are more likely to be prescribed long-term and multiple medications which can lead to unintentional misuse. With more people living longer, the potential for problems grows. It is incumbent to realize help is available for seniors, and that there are direct health benefits as well as an improved quality of life. Participants will learn the signs and symptoms of addiction and learn to identify the most effective treatment and intervention programs for those 50 and older. |
| Learning Objectives |
1. Describe the successful icanhelpsm program’s three-pronged approach for early engagement of adolescents most at-risk of addiction.
2. Explain the importance of educating the caregivers and others of the elderly (over 50) population on the potential for prescription drug misuse, abuse, addiction and becoming victims of pill-seekers.
3. Describe the essential services needed to provide both the youth and the elderly an opportunity to live productive, healthy lives, and identify common barriers to accessing treatment. |
|
Creative Solutions in Lean Budget Times
Wednesday, April 11, 2012, 3:15 pm – 4:45 pm |
| Moderator |
Margaret-Jaree Baker, MA, Treatment Referral Coordinator, Operation UNITE |
| Presenters |
Leslie Balonick, Senior Vice President-Eastern Division, WestCare Foundation; and Mike Townsend, Executive Director, Recovery Kentucky Program, Kentucky Housing Corporation |
| Session Description |
The U.S. Department of Justice estimates two-thirds of drug offenders will be re-arrested within three years. Millions of dollars are spent prosecuting and incarcerating these offenders without addressing the underlying need for treatment and recovery. Meeting the demand for drug treatment and recovery can be a challenge when budgets are tight. For many, access to treatment only occurs following an arrest. Two states will share their approaches to providing treatment/recovery as alternatives.
In recognizing that drugs are a leading cause of recidivism, the Illinois Department of Corrections teamed up with partners and community-based providers to create an intensive prison-based drug treatment, vocational training and job preparation program that culminates with an extensive case management and highly supervised community reentry program upon completion of their sentence. This has resulted in a 40 percent decrease in recidivism among this population. Kentucky, which has been hit hard by the prescription drug epidemic, was in desperate need for treatment beds. The Recovery Kentucky program utilized a strategic use of tax credits to fund housing recovery centers designed to simultaneously resolve the state’s drug problem and homeless issues. |
| Learning Objectives |
1. Describe the successful Recovery Kentucky program as a means to provide additional recovery centers.
2. Describe the primary outcome of the Sheridan Program – reduced recidivism – and how this outcome is affected by intermediate program outcomes such as completion of the therapeutic community, admission and retention in community treatment, and completion of case management requirements.
3. Evaluate the cost of incarceration versus the cost of providing treatment/recovery services. |
|
